{"id":65865,"date":"2026-03-30T10:56:50","date_gmt":"2026-03-30T05:26:50","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=65865"},"modified":"2026-03-30T10:56:52","modified_gmt":"2026-03-30T05:26:52","slug":"beta-drugs-q4-fy26-results-expectations","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/beta-drugs-q4-fy26-results-expectations\/","title":{"rendered":"Beta Drugs Q4 FY26 Results Preview &#038; Earnings Outlook"},"content":{"rendered":"<p><strong><em>Beta Drugs latest news:<\/em><\/strong> Beta Drugs Q4 FY26 results date is all set to be announced soon and most investors are awaiting it. Professionals are expecting an increase in revenue due to higher sales and a significant rise in PAT. Beta Drugs was listed on the National Stock Exchange (NSE) on 24-Nov-2025. Beta Drugs share has its face value of 10 per share, and its NSE symbol is BETA. The company operates in the Healthcare sector and primarily belongs to the Pharmaceuticals industry.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-q4-fy26-results-expectations\/#Beta_Drugs_Q4_Results_2026_Preview\" title=\"Beta Drugs Q4 Results 2026 Preview\">Beta Drugs Q4 Results 2026 Preview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-q4-fy26-results-expectations\/#Beta_Drugs_Share_Performance\" title=\"Beta Drugs Share Performance\">Beta Drugs Share Performance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-q4-fy26-results-expectations\/#Key_Factors_to_Watch_for_Beta_Drugs_Q4_Results_FY26\" title=\"Key Factors to Watch for Beta Drugs Q4 Results FY26\">Key Factors to Watch for Beta Drugs Q4 Results FY26<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-q4-fy26-results-expectations\/#About_Beta_Drugs\" title=\"About Beta Drugs\">About Beta Drugs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-q4-fy26-results-expectations\/#Final_Thoughts\" title=\"Final Thoughts\">Final Thoughts<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/beta-drugs-q4-fy26-results-expectations\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Beta_Drugs_Q4_Results_2026_Preview\"><\/span><strong>Beta Drugs Q4 Results 2026 Preview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\"><li>Beta Drugs Q4 FY26 revenue is expected to be around Strong Growth Expected, representing a 14-20% YoY increase compared to the same quarter last year.<\/li>\n\n<li>Profit After Tax, or PAT, is projected to rise 18-25% YoY.<\/li>\n\n<li>EBITDA to rise 20%.<\/li>\n\n<li>Beta Drugs is expected to show Strong Growth Expected in its revenue.&nbsp;<\/li><\/ul><p><a href=\"https:\/\/univest.in\/user\/log-in\">Click and Sign Up to Get Live Updates on Q4 Results<\/a><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Beta_Drugs_Share_Performance\"><\/span><strong>Beta Drugs Share Performance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\"><li>Over the past six months, Beta Drugs share price has 28% by 15-20% to 1192.5.<\/li>\n\n<li>Moreover, over the past year, the stock has 52% by Up<\/li>\n\n<li>Despite this weak short-term performance, Beta Drugs stock has delivered a financially sound 240% return over the past 5 years.<\/li>\n\n<li>As of today, 27-03-2026, the Beta Drugs share price is trading at 1192.5 per share.<\/li><\/ul><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Factors_to_Watch_for_Beta_Drugs_Q4_Results_FY26\"><\/span><strong>Key Factors to Watch for Beta Drugs Q4 Results FY26<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><ul class=\"wp-block-list\"><li><strong>Revenue Growth &amp; Segment Performance<\/strong> \u2013 Focus on topline growth in the Pharmaceuticals industry within the Healthcare sector.<\/li>\n\n<li><strong>Occupancy Levels &amp; Seat Expansion<\/strong> \u2013 Monitor operational expansion and capacity utilisation trends.<\/li>\n\n<li><strong>Profitability &amp; Margin Trends<\/strong> \u2013 Track EBITDA and PAT margins to evaluate cost control and operating efficiency.<\/li>\n\n<li><strong>Order Book &amp; New Client Wins<\/strong> \u2013 Watch for updates on new contracts, partnerships, and long-term deals.<\/li>\n\n<li><strong>Balance Sheet &amp; Cash Flow Position<\/strong> \u2013 Review debt levels, working capital management, and operating cash flows for financial stability.<\/li><\/ul><p><em>Visit Univest app or website to check more <\/em><strong><em>Beta Drugs latest news <\/em><\/strong><em>to make an informed investment decision.&nbsp;<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_Beta_Drugs\"><\/span><strong>About Beta Drugs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Beta Drugs develops oncology-focused pharmaceutical products for domestic and export markets. The company specializes in niche cancer therapies, benefiting from growing demand in oncology treatment, while focusing on R&amp;D, regulatory approvals, and expanding its global footprint.<\/p><p><em>Visit Univest app or website to check more <\/em><strong><em>Beta Drugs latest news <\/em><\/strong><em>to make an informed investment decision.&nbsp;<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Final_Thoughts\"><\/span><strong>Final Thoughts<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Beta Drugs is gear up to announce its Q4 FY26 results. <strong>Analysts expect 14-20% revenue growth, a 18-25% rise in PAT, and a 20% rise in EBITDA.<\/strong> Beta Drugs focuses on revenue growth from order execution, margin improvement, a strong order book, and management.<\/p><p>Stay informed with Univest blogs to get real-time updates on Beta Drugs Q4 results FY26.&nbsp;<\/p><p><strong><em>Disclaimer: <\/em><\/strong><em>Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.<\/em><\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/best-agrolife-q4-fy26-results-expectations\">Best Agrolife Q4 FY26 Results Preview &amp; Earnings Expectations<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/bhansali-engineering-polymers-q4-fy26-results-expectations\">Bhansali Engineering Polymers Q4 FY26 Results Preview &amp; Earnings Outlook<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/berger-paints-q4-fy26-results-expectations\">Berger Paints Q4 FY26 Results Preview &amp; Earnings Outlook<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/beml-q4-fy26-results-expectations\">BEML Q4 FY26 Results Preview &amp; Earnings Outlook<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/belrise-industries-q4-fy26-results-expectations\">Belrise Industries Q4 FY26 Results Preview &amp; Earnings Outlook<br><\/a><br><a href=\"https:\/\/univest.in\/blogs\/beml-q4-fy26-results-expectations\"><br><\/a><br><a href=\"https:\/\/univest.in\/blogs\/berger-paints-q4-fy26-results-expectations\"><br><\/a><br><a href=\"https:\/\/univest.in\/blogs\/bhansali-engineering-polymers-q4-fy26-results-expectations\"><br><\/a><br><a href=\"https:\/\/univest.in\/blogs\/best-agrolife-q4-fy26-results-expectations\"><br><\/a><br><\/p>","protected":false},"excerpt":{"rendered":"<p>Beta Drugs latest news: Beta Drugs Q4 FY26 results date is all set to be announced soon and most investors are awaiting it. Professionals are expecting an increase in revenue due to higher sales and a significant rise in PAT. Beta Drugs was listed on the National Stock Exchange (NSE) on 24-Nov-2025. Beta Drugs share<\/p>\n","protected":false},"author":28,"featured_media":65867,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,842],"tags":[3802,3862],"class_list":["post-65865","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","category-news","tag-news","tag-q4-results-expectations"],"metadata":{"_edit_lock":["1774848472:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_seo_score":["66"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_primary_category":["1"],"rank_math_description":["Beta Drugs Q4 FY26 results earnings preview covering oncology pharma outlook revenue expectations and margin trends"],"rank_math_title":["Beta Drugs Q4 FY26 Results Preview and Earnings Outlook"],"rank_math_focus_keyword":["Beta Drugs Q4 FY26 Results"],"rank_math_robots":["a:2:{i:0;s:8:\"nofollow\";i:1;s:7:\"noindex\";}"],"_thumbnail_id":["65867"],"rank_math_analytic_object_id":["7242"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2026\/03\/30105346\/Beta-Drugs-Q4-Results-Expectations.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/65865","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=65865"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/65865\/revisions"}],"predecessor-version":[{"id":65868,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/65865\/revisions\/65868"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/65867"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=65865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=65865"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=65865"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}